Identification of a Novel Frameshift Mutation in the DMD Gene as the Cause of Muscular Dystrophy in a Norfolk Terrier Dog
Tufts' Canine and Feline Breeding and Genetics Conference, 2015
C.A. Jenkins; O.P. Forman; C.S. Mellersh
Kennel Club Genetics Centre, Animal Health Trust, Lanwades Park, Newmarket, Suffolk, UK

Dystrophin-deficient muscular dystrophy (DD-MD) is an X-linked disease in humans (Duchenne muscular dystrophy, DMD) and dogs. In DD-MD the lack of functional dystrophin protein causes advancing muscle weakness, respiratory problems, and cardiomyopathy. This results in the loss of mobility and reduced life expectancy. Dystrophin-deficient muscular dystrophy is currently incurable, and the dog is an ideal model for the disease because the canine phenotype is very similar to that seen in humans. A six-month-old Norfolk terrier was referred to the Animal Health Trust neurology unit with suspected DD-MD, which was confirmed by clinical investigations and muscle biopsy results. Dystrophin-deficient muscular dystrophy had not been previously described in this breed. We carried out exon resequencing of the canine Duchenne muscular dystrophy (DMD) gene to screen for potential disease-causing mutations. The sequence data generated from all coding DMD exons revealed a 1-bp deletion in exon 22, causing a frameshift and premature termination of the coding sequence. Gene expression analysis (quantitative PCR) indicated reduced levels of dystrophin transcript in the DD-MD case and the absence of full-length dystrophin protein was confirmed by western blotting. The finding represents a novel mutation causing DD-MD in the dog.


Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

C.A. Jenkins
Kennel Club Genetics Centre
Animal Health Trust, Lanwades Park
Newmarket, Suffolk, UK

MAIN : Posters : Muscular Dystrophy in Norfolk Terrier Dog
Powered By VIN